Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $29.5000 (7.27%) ($27.8900 - $29.6000) on Tue. Mar. 22, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.85% (three month average) | RSI | 77 | Latest Price | $29.5000(7.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 4.6% a day on average for past five trading days. | Weekly Trend | CAPR advances 11.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) EWG(7%) EWI(7%) PEJ(7%) VT(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.925% in a week (0% probabilities). VIXM(-5%) TLT(-5%) GLD(-4%) GDX(-4%) SLV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.925% (StdDev 5.85%) | Hourly BBV | 0 () | Intraday Trend | 5.7% | | | |
|
5 Day Moving Average | $26.98(9.34%) | 10 Day Moving Average | $24.6(19.92%) | 20 Day Moving Average | $23.68(24.58%) | To recent high | -10.1% | To recent low | 46.8% | Market Cap | $581m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |